USA — NDC
Intrarosa 6.5 mg (Prasterone) Ovule
GNH USA supplies Intrarosa 6.5 mg (Prasterone), an androgen for treating dyspareunia associated with vulvar and vaginal atrophy.
Request sourcing
What is Prasterone?
Prasterone, the active ingredient in Intrarosa 6.5 mg, is an androgen (steroid hormone) presented as a 6.5 mg vaginal ovule for vaginal use. It is used to treat painful sexual intercourse in postmenopausal women due to vulvar and vaginal atrophy.
GNH USA supplies Intrarosa 6.5 mg as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide.
What is Prasterone used for?
Intrarosa 6.5 mg is indicated for the treatment of dyspareunia (painful sexual intercourse) associated with vulvar and vaginal atrophy (VVA) in postmenopausal women.
- Dyspareunia: Reduces moderate to severe pain during sexual intercourse due to vaginal changes related to menopause. - Vulvar and vaginal atrophy (VVA): Improves vaginal tissue and symptoms associated with menopause-related atrophy.
What are the side effects of Prasterone?
The use of Intrarosa 6.5 mg may cause certain side effects. Common Side Effects: - Vaginal discharge: May occur during treatment. - Changes on Pap smear: Abnormal results may be observed.
Serious or Rare Side Effects: - Allergic reactions: Symptoms such as rash, itching, swelling, severe dizziness, or trouble breathing may occur. - Vaginal bleeding: Unchecked vaginal bleeding should be evaluated by a healthcare provider. - Breast cancer: Prasterone is converted to estrogen, which is not recommended for women with a history of breast cancer.
What precautions apply to Prasterone?
Intrarosa 6.5 mg should be used with caution and under the supervision of a healthcare provider. Inform your doctor if you have a history of breast cancer or unexplained vaginal bleeding. Avoid use during pregnancy and breastfeeding. Store at room temperature: Keep away from moisture and heat.
What does Prasterone interact with?
Intrarosa 6.5 mg may interact with other medications. Major Interactions (Avoid): - Estrogen therapies: Concurrent use with estrogen-based treatments may increase the risk of side effects. - Hormonal therapies: May affect the efficacy and safety of other hormonal medications.
Moderate Interactions (Monitor Closely): - Breast cancer treatments: Monitor for potential interactions and side effects. - Vaginal infections: May require additional monitoring and treatment adjustments.



